ACTIVE

AMOPHAR

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
-138,1 k €
+67.2% YoY
Gross margin
83,2 k €
+61.5% YoY
Equity
-1 M €
-15.7% YoY
Workforce
1,8 ETP
-69.0% YoY

What does AMOPHAR do?

AMOPHAR is a Private limited company incorporated in 2011. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Schelle. It employs on average 1,8 ETP workers (FTE).

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0839.385.540
Incorporation
09/09/2011
Legal form
Private limited company
Registered office
Molenberglei 36
2627 Schelle · FlandreSee on map
Contributed capital
20 000,00 €
Latest accounts
31/12/2025
Average workforce
1,8 ETP
Activities (NACE)
46460Wholesale of pharmaceutical goods· main46460Wholesale of pharmaceutical goods
Joint committees (4)
  • 100
  • 1000
  • 200
  • 2000
Signals
Healthy social debts
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 13 financial years

2025202420232022202120192018201720162015201420132012
Income statement
Gross margin83,2 k €51,5 k €528,3 k €194,2 k €866,1 k €-15,9 k €278 k €491,8 k €314,8 k €24,7 k €78,4 k €201,5 k €–
EBITDA-148,3 k €-418,7 k €-135,3 k €-488,9 k €205,3 k €-307,1 k €-43 k €473,5 k €295,6 k €12,2 k €53,8 k €176,5 k €-50,5 k €
Operating result-155,9 k €-428,4 k €-148,7 k €-509,9 k €178,5 k €-318,2 k €-45,5 k €473,5 k €295,6 k €-9,5 k €12,2 k €134,9 k €-50,5 k €
Net result-138,1 k €-421,1 k €-153,3 k €-509,5 k €113,5 k €-319,5 k €-48,5 k €310 k €198,6 k €-9,6 k €8,2 k €106,2 k €-50,5 k €
Balance sheet
Equity-1 M €-879,7 k €-458,6 k €-305,3 k €204,2 k €-345 k €-25,5 k €23 k €22,9 k €14,3 k €23,8 k €25,7 k €74,5 k €
Total assets401,3 k €434,4 k €1 M €910,9 k €1,2 M €457,8 k €669,2 k €681,4 k €352,8 k €93,7 k €113 k €116 k €154,9 k €
Cash10,5 k €8,6 k €38,1 k €41,6 k €248,1 k €48,9 k €32,2 k €34,4 k €46,9 k €6,8 k €15,7 k €23,4 k €17,4 k €
Debts1,4 M €1,3 M €1,5 M €1,2 M €994,7 k €802,8 k €694,7 k €658,4 k €329,9 k €79,5 k €89,2 k €90,4 k €80,5 k €
Other
Workforce1,8 ETP5,8 ETP7,8 ETP7,8 ETP8,4 ETP3,8 ETP1,7 ETP–––––0,9 ETP
Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 17 ended

Active mandates

LBS

Director · since 09 juillet 2020 · 0561.780.151

Represented by Asselman Lode

Active
INPHAGRO

Director · since 29 mai 2018 · 0664.787.322

Represented by Mc Cullough Sean

Active

Ended mandates

AMEXCON

Director · since 07 juin 2021 · until 09 juin 2023 · 0466.332.745

Represented by Bart Ameije

Ended
AMEXCON

Bestuurder · since 07 juin 2021 · until 24 mai 2023 · 0466.332.745

Represented by Bart Ameije

Ended
AMEXCON BV

Bestuurder · since 07 juin 2021

Represented by Bart Ameije

Ended
LBS

Director · since 09 juillet 2020 · 0561.780.151

Represented by Lode Asselman

Ended
At this address

Other companies at this address

CompanyCBE no.
ALL-in-1● Active
0864.603.461
Amophar OTC● Active
0795.483.142
INPHAGRO● Active
0664.787.322
KDT Consulting● Active
0877.577.806
LIFE MEDICAL● Active
0561.721.456
WOLFMAN● Active
0750.605.497
Annual accounts

Full financial information

202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date09/07/202626/06/202519/11/202416/10/202306/10/202223/09/2021
General meeting30/06/202610/06/202505/11/202406/10/202322/09/202220/09/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

14 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202530/06/202609/07/2026DutchPDF
Abridged model31/12/202410/06/202526/06/2025DutchPDF
Abridged model31/12/202305/11/202419/11/2024DutchPDF
Abridged model31/12/202206/10/202316/10/2023DutchPDF
Abridged model31/12/202122/09/202206/10/2022DutchPDF
Abridged model31/12/202020/09/202123/09/2021DutchPDF
Abridged model31/12/201910/07/202027/08/2020DutchPDF
Abridged model31/12/201830/08/201930/08/2019DutchPDF
Abridged model31/12/201713/06/201822/06/2018DutchPDF
Abridged model31/12/201614/04/201719/04/2017DutchPDF
Abridged model31/12/201514/06/201629/07/2016DutchPDF
Abridged model31/12/201409/06/201518/06/2015DutchPDF
Abridged model31/12/201311/04/201411/04/2014DutchPDF
Full model31/12/201219/07/201319/07/2013DutchPDF
Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 17 ended

Active mandates

LBS

Director · since 09 juillet 2020 · 0561.780.151

Represented by Asselman Lode

Active
INPHAGRO

Director · since 29 mai 2018 · 0664.787.322

Represented by Mc Cullough Sean

Active

Ended mandates

AMEXCON

Director · since 07 juin 2021 · until 09 juin 2023 · 0466.332.745

Represented by Bart Ameije

Ended
AMEXCON

Bestuurder · since 07 juin 2021 · until 24 mai 2023 · 0466.332.745

Represented by Bart Ameije

Ended
AMEXCON BV

Bestuurder · since 07 juin 2021

Represented by Bart Ameije

Ended
LBS

Director · since 09 juillet 2020 · 0561.780.151

Represented by Lode Asselman

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates02/07/2021
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other13/10/2020
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates20/08/2020
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other10/06/2020
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM
    PDF
  • Mandates31/01/2019
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates06/06/2018
    DIVERSEN - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates17/07/2015
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates19/05/2014
    ONTSLAGEN - BENOEMINGEN
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-138,1 k €↑
  2. 2024
    Annual accounts 2024-421,1 k €↓
  3. 2023
    Annual accounts 2023-153,3 k €↑
  4. 2022
    Annual accounts 2022-509,5 k €↓
  5. 2021
    Annual accounts 2021113,5 k €↑
  6. 2019
    Annual accounts 2019-319,5 k €↓
  7. 2018
    Annual accounts 2018-48,5 k €↓
  8. 2017
    Annual accounts 2017310 k €↑
  9. 2016
    Annual accounts 2016198,6 k €↑
  10. 2015
    Annual accounts 2015-9,6 k €↓
  11. 2014
    Annual accounts 20148,2 k €↓
  12. 2013
    Annual accounts 2013106,2 k €↑
  13. 2012
    Annual accounts 2012-50,5 k €
  14. 09/09/2011
    IncorporationPrivate limited company